Wei Zhang

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer

Zhe-Sheng Chen, Chaohua Hu, Zhuoxun Wu, 2020, Molecular Cancer.

Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance.

Zhe-Sheng Chen, N. Ji, Liying Ma, 2019, European journal of pharmacology.

An organoruthenium complex overcomes ABCG2-mediated multidrug resistance via multiple mechanisms.

Zhe-Sheng Chen, J. Li, C. Ashby, 2019, Chemical communications.

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression

Zhe-Sheng Chen, Dong-Hua Yang, Jing-Quan Wang, 2019, Molecules.

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.

Zhe-Sheng Chen, Dong-Hua Yang, Pranav Gupta, 2018, Cancer letters.

Inhibiting ERK5 overcomes breast cancer resistance to anti-HER2 therapy by targeting the G1/S cell cycle transition.

N. Gray, B. Telfer, Jinhua Wang, 2022, Cancer research communications.

Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor.

Zhe-Sheng Chen, Cai-Ping Tan, Bo Wang, 2020, Biochemical pharmacology.

Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model

Zhe-Sheng Chen, Dong-Hua Yang, J. Wurpel, 2021, Frontiers in Cell and Developmental Biology.

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

Zhe-Sheng Chen, Pranav Gupta, Leli Zeng, 2018, Front. Pharmacol..

Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell Line

Zhe-Sheng Chen, Dong-Hua Yang, J. Wurpel, 2020, Frontiers in Cell and Developmental Biology.

Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor.

J. Wurpel, Zhuoxun Wu, Jing-Quan Wang, 2023, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.